Mohammed Rawway
Impact in
- Small Animals top 5%
- Brucella: diagnosis, epidemiology, treatment
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Protein Hydrolysis and Bioactive Peptides 2
-
- Bacterial Identification and Susceptibility Testing 5
- Co-authors
- Adil Abalkhail (10 shared papers)Ayman Elbehiry (10 shared papers)Eman Marzouk (9 shared papers)Musaad Aldubaib (6 shared papers)Ihab Mohamed Moussa (5 shared papers)Abdulaziz M. Almuzaini (4 shared papers)Sulaiman Anagreyyah (3 shared papers)Abdelmaged Draz (4 shared papers)
- Journals
- Vaccines (3 papers)PLoS ONE (2 papers)Archives of Microbiology (2 papers)Antibiotics (1 paper)SpringerPlus (1 paper)
- Partner nations
- EgyptSaudi ArabiaTaiwan
In The Last Decade
Mohammed Rawway
17 papers receiving 407 citations
Mohammed Rawway's Hit Papers
Peers
Comparison fields: 5 of 72
- Small Animals 77
- Molecular Medicine 49
- Applied Microbiology and Biotechnology 14
- Clinical Biochemistry 38
- Biotechnology 50
Countries citing papers authored by Mohammed Rawway
This map shows the geographic impact of Mohammed Rawway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Rawway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Rawway more than expected).
Fields of papers citing papers by Mohammed Rawway
This network shows the impact of papers produced by Mohammed Rawway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Rawway. The network helps show where Mohammed Rawway may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohammed Rawway, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Helicobacter pylori Infection: Current Status and Future Prospects on Diagnostic, Therapeutic and Control Challenges Hit paper breakdown → | 2023 | 101 |
| 2 | 2022 | 63 | |
| 3 | 2022 | 54 | |
| 4 | 2023 | 35 | |
| 5 | 2018 | 31 | |
| 6 | 2022 | 27 | |
| 7 | 2021 | 21 | |
| 8 | 2022 | 15 | |
| 9 | 2022 | 14 | |
| 10 | 2018 | 13 | |
| 11 | 2023 | 10 | |
| 12 | 2024 | 8 | |
| 13 | 2018 | 8 | |
| 14 | 2024 | 6 | |
| 15 | 2022 | 5 | |
| 16 | 2014 | 2 | |
| 17 | 2020 | 1 | |
| 18 | 2026 | 0 | |
| 19 | 2017 | 0 |
About Mohammed Rawway
Mohammed Rawway is a scholar working on Molecular Biology, Clinical Biochemistry, Small Animals, Molecular Medicine and Nutrition and Dietetics, having authored 19 papers that have together received 414 indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (5 papers), Brucella: diagnosis, epidemiology, treatment (3 papers), Antibiotic Resistance in Bacteria (3 papers), Enzyme Production and Characterization (3 papers), Galectins and Cancer Biology (2 papers), Algal biology and biofuel production (2 papers), Nanoparticles: synthesis and applications (2 papers) and Protein Hydrolysis and Bioactive Peptides (2 papers). The work is most often cited by research in Small Animals (77 citations), Molecular Medicine (49 citations), Applied Microbiology and Biotechnology (14 citations), Clinical Biochemistry (38 citations) and Biotechnology (50 citations). Mohammed Rawway has collaborated with scholars based in Egypt, Saudi Arabia and Taiwan. Frequent co-authors include Adil Abalkhail, Ayman Elbehiry, Eman Marzouk, Musaad Aldubaib, Ihab Mohamed Moussa, Abdulaziz M. Almuzaini, Sulaiman Anagreyyah, Abdelmaged Draz, Mai Ibrahem and Akram Abu-Okail. Their work appears in journals such as Vaccines, PLoS ONE, Archives of Microbiology, Antibiotics and SpringerPlus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.